Literature DB >> 10619262

Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas.

S Nagura1, R Katoh, A Kawaoi, M Kobayashi, T Obara, K Omata.   

Abstract

To determine the usefulness of immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas (PC), 42 cases of PC (33 adrenal and nine extra-adrenal tumors) were studied by immunohistochemistry using the monoclonal antibody, MIB-1. The mean MIB-1-positive cell rate for all 42 PCs was low (1.4%). The MIB-1-positive cell rates of adrenal PCs were significantly higher in malignant tumors (mean, 3.30%) than in benign tumors (mean, 0.81%) (P = .0184). In extra-adrenal PCs, the difference between benign (mean, 0.44%) and malignant (mean, 5.10%) tumors was also statistically significant (P = .0004). Other clinicopathologic factors, including family history, age, sex, and multiple endocrine neoplasm (MEN) type II status were also examined and were not statistically significant. In conclusion, estimation of the MIB-1-positive cell rate is useful for histologic distinction between benign and malignant pheochromocytomas. Especially, it is important to note that a high MIB-1-positive cell rate (>2%) is highly suggestive of malignancy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619262

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  12 in total

1.  Malignant paraganglioma of the urinary bladder: Immunohistochemical study of prognostic indicators.

Authors:  Kalman Kovacs; David Bell; Geoffrey W Gardiner; R John Honey; Jeannette Goguen; Fabio Rotondo
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors.

Authors:  Noriko Kimura; Toshiya Watanabe; Takao Noshiro; Soichiro Shizawa; Yukio Miura
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 3.  Differential diagnosis of pheochromocytomas and paragangliomas.

Authors:  A M McNichol
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

Review 4.  New developments in the detection of the clinical behavior of pheochromocytomas and paragangliomas.

Authors:  Ronald R de Krijger; Francien H van Nederveen; Esther Korpershoek; Winand N M Dinjens
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

5.  Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques.

Authors:  Nobue Kumaki; Hiroshi Kajiwara; Kaori Kameyama; Ronald A DeLellis; Sylvia L Asa; R Yoshiyuki Osamura; Hiroshi Takami
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

6.  N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma.

Authors:  Amir Khorram-Manesh; Håkan Ahlman; Svante Jansson; Ola Nilsson
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 7.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 8.  Histopathology and immunohistochemistry of adrenal medullary tumors and paragangliomas.

Authors:  Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 9.  Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry.

Authors:  C Christofer Juhlin
Journal:  Endocr Pathol       Date:  2021-03-25       Impact factor: 3.943

10.  Paraganglioma of the posterior mediastinum diagnosed by immunohistochemical staining.

Authors:  Naoyuki Yoshino; Takao Hisayoshi; Yuji Maruyama; Hidetsugu Ogasawara; Shigeo Yamauchi; Yoshiharu Oaki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.